CN Stock MarketDetailed Quotes

002755 Beijing Aosaikang Pharmaceutical

Watchlist
  • 14.14
  • +0.04+0.28%
Market Closed Nov 29 15:00 CST
13.12BMarket Cap80.34P/E (TTM)

About Beijing Aosaikang Pharmaceutical Company

The company was founded in 2003 and originated from the Nanjing Haiguang Institute of Applied Chemistry, one of the earliest private drug research and development institutions in Jiangsu Province. In 2019, the company officially entered the capital market. The company is a pharmaceutical manufacturing enterprise driven by innovation and research. The company's drug treatment field has covered the four major fields of digestion, anti-tumor, anti-infection, and chronic diseases, and its business covers R&D, production and sales of raw materials and formulations. Main Products: Omeprazole Sodium for Injection, Dexlansoprazole for Injection, Rosatidine Acetate for Injection, Esomeprazole Magnesium Dry Enteric Suspension, Esomeprazole Sodium for Injection, Lansoprazole for Injection, Rabeprazole Sodium for Injection, Dextrozosin for Injection, Nedaplatin for Injection, Temozolomide for Injection, Temozolomide Capsules, Lentivanib Mesylate Capsules, Pipribacil Capsules Fenn tablets, decitabine for injection, docetaxel injection, pemetrexed disodium for injection, zoledronic acid concentrated solution for injection, palonosetron hydrochloride injection , tigecycline for injection, posaconazole injection, posaconazole enteric tablets, polymyxin E sodium mesylate for injection, voriconazole for injection, daptomycin for injection, and saxagliptin tablets. Corporate honors: “Advanced Quality and Safety Management Unit”, “National Excellent Construction Enterprise for Production Safety”, “National Petroleum Reserve Phase I Project Technology Promotion and Application Advanced Collective”, “National Petroleum Reserve Phase I Project Technology Promotion and Application Special Advanced Collective”, “National Engineering Survey and Geotechnical Industry Top 10 Independent Technology Innovation Enterprise Award”, “AAA Enterprise Credit Rating”, “Science and Technology Innovation Enterprise Award”, “National Advanced Unit for Engineering Construction Safety”, “Excellent Petrochemical Engineering Construction Enterprise”, “Excellent Petrochemical Engineering Construction Enterprise”, won the Nanjing Municipal Civilized Unit, Nanjing Harmonious Labor Relations Demonstration Enterprise Honorary titles such as Enterprise, Little Family of Advanced Workers in Jiangning District, Nanjing, and Worker Pioneer.

Company Profile

Short Name-A奥赛康
Symbol-A002755
Company NameBeijing Aosaikang Pharmaceutical Co.,Ltd.
Listing DateMay 15, 2015
Issue Price7.49
Shares Offered25.34M share(s)
FoundedDec 24, 1996
Listed ExchangeSZ Stock Exchange
Legal Representativeqingcai chen
General Managerjingfei ma
Secretaryjingfei ma
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities Representativeyanyan wang
Legal CounselGuo Hao Law Firm (Nanjing)
Employees19
Phone025-52292222
Office AddressNo. 699 Kejian Road, Jiangning Science Park, Nanjing
Zip Code211112
Registered AddressBuilding 28, District 7, No. 188, South Fourth Ring West Road, Fengtai District, Beijing
Fax025-52169333
Emailir@ask-pharm.com
Business License110000011167914
BusinessCompany business scope: medical research and experimental development; technical consulting, technical services; import and export of goods, technology import and export; enterprise management; sales of chemical products. (Enterprises independently select business projects and carry out business activities in accordance with the law; sell chemical products and projects subject to approval according to law, carry out business activities in accordance with the approved content after approval by the relevant departments; they are not allowed to engage in business activities for projects prohibited or restricted by Beijing's industrial policy.)

Company Executives

  • Name
  • Position
  • Salary
  • qingcai chen
  • Chairman, Directors, Nomination Committee Members, Chairman of the Strategy Committee, Member of the Remuneration and Assessment Committee
  • 1.89M
  • suling zhou
  • Directors
  • --
  • youyin xu
  • Directors, Deputy General Manager, Strategy Committee Members
  • 2.00M
  • xiaowen wang
  • Directors
  • 670.00K
  • xiangfeng chen
  • Directors, Strategy Committee Members, Audit Committee Members
  • 1.00M
  • jingfei ma
  • Directors, Board Secretary, General Manager
  • 900.00K
  • jianwen liu
  • Independent Directors, Chairman of the Nomination Committee, Audit Committee Members
  • 100.00K
  • xiaoming wu
  • Independent Directors, Nomination Committee Members, Chairman of the Remuneration and Assessment Committee
  • 100.00K
  • di li
  • Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
  • 100.00K
  • yanyan wang
  • Securities Affairs Representative
  • --
  • jing chen
  • Chairman of the Supervisory Board, Auditors
  • 800.00K
  • tao han
  • Chief Financial Officer
  • 800.00K
  • guigen zhang
  • Head of Internal Audit
  • --
  • hongfang xue
  • Employee Supervisors
  • 300.00K
  • yanrong zhao
  • Employee Supervisors
  • 400.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data